Gene and cytokine therapy for heart failure: molecular mechanisms in the improvement of cardiac function.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  American Journal of Physiology. Heart and Circulatory Physiology

• Publication date

  2012-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1152/ajpheart.00130.2012PMID 22777420
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• AAV6.βARKct cardiac gene therapy ameliorates cardiac function and normalizes the catecholaminergic axis in a clinically relevant large animal heart failure model.

  2013cited by this paper
• Gene Therapy for Heart Failure

  2012cited by this paper
• Erythropoietin induces positive inotropic and lusitropic effects in murine and human myocardium.

  2012cited by this paper
• AAV6-βARKct gene delivery mediated by molecular cardiac surgery with recirculating delivery (MCARD) in sheep results in robust gene expression and increased adrenergic reserve.

  2012cited by this paper
• Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease.

  2012cited by this paper
• Pathophysiology of Heart Failure

  2012cited by this paper
• Neuregulin-1β for the treatment of systolic heart failure.

  2011cited by this paper
• Cardiac AAV9-S100A1 Gene Therapy Rescues Post-Ischemic Heart Failure in a Preclinical Large Animal Model

  2011cited by this paper
• Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): A Phase 2 Trial of Intracoronary Gene Therapy of Sarcoplasmic Reticulum Ca2+-ATPase in Patients With Advanced Heart Failure

  2011cited by this paper
• Erythropoietin as a treatment of anemia in heart failure: systematic review of randomized trials.

  2011cited by this paper
• Unanticipated signaling events associated with cardiac adenylyl cyclase gene transfer.

  2011cited by this paper
• Where are the new drugs to treat heart failure? Introduction to the special issue on "key signaling molecules in hypertrophy and heart failure".

  2011cited by this paper
• Role of Cardiac Stem Cells in Cardiac Pathophysiology: A Paradigm Shift in Human Myocardial Biology

  2011cited by this paper
• S100A1 genetically targeted therapy reverses dysfunction of human failing cardiomyocytes.

  2011cited by this paper
• Cardiac myosin activation part 1: from concept to clinic.

  2011cited by this paper
• Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease.

  2011cited by this paper
• Rescuing the failing heart by targeted gene transfer.

  2011cited by this paper
• Cardiac Gene Transfer of Short Hairpin RNA Directed Against Phospholamban Effectively Knocks Down Gene Expression but Causes Cellular Toxicity in Canines

  2011cited by this paper
• Erythropoietin preserves the endothelial differentiation capacity of cardiac progenitor cells and reduces heart failure during anticancer therapies.

  2011cited by this paper
• S100A1 gene therapy for heart failure: a novel strategy on the verge of clinical trials.

  2011cited by this paper
• Gene therapy for ischemic heart disease.

  2011cited by this paper
• Erythropoietin Activates Mitochondrial Biogenesis and Couples Red Cell Mass to Mitochondrial Mass in the Heart

  2010cited by this paper
• A single dose of erythropoietin in ST-elevation myocardial infarction.

  2010cited by this paper
• Vascular endothelial growth factor is crucial for erythropoietin-induced improvement of cardiac function in heart failure.

  2010cited by this paper
• Gene Delivery of Sarcoplasmic Reticulum Calcium ATPase Inhibits Ventricular Remodeling in Ischemic Mitral Regurgitation

  2010cited by this paper
• Recent advances in lentiviral vector development and applications.

  2010cited by this paper
• Erythropoietin in Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Randomized, Double-Blind Trial

  2010cited by this paper
• Cell therapy for the treatment of coronary heart disease: a critical appraisal

  2010cited by this paper
• Constitutively active phosphatase inhibitor-1 improves cardiac contractility in young mice but is deleterious after catecholaminergic stress and with aging.

  2010cited by this paper
• Sonic hedgehog is a critical mediator of erythropoietin-induced cardiac protection in mice.

  2010cited by this paper
• Design and rationale of the Reduction of Infarct Expansion and Ventricular Remodeling with Erythropoietin after Large Myocardial Infarction (REVEAL) trial.

  2010cited by this paper
• β-Adrenergic stimulation and myocardial function in the failing heart

  2009cited by this paper
• Update on phase II studies of erythropoietin in acute myocardial infarction. Rationale and design of Exogenous erythroPoietin in Acute Myocardial Infarction: New Outlook aNd Dose Association Study (EPAMINONDAS)

  2009cited by this paper
• Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1/2 clinical trial.

  2009cited by this paper
• Myocardial Adeno-Associated Virus Serotype 6–&bgr;ARKct Gene Therapy Improves Cardiac Function and Normalizes the Neurohormonal Axis in Chronic Heart Failure

  2009cited by this paper
• Granulocyte colony-stimulating factor protects cardiac mitochondria in the early phase of cardiac injury.

  2009cited by this paper
• Rescue of Ca2+ overload-induced left ventricular dysfunction by targeted ablation of phospholamban.

  2009cited by this paper
• Reversal of cardiac myocyte dysfunction as a unique mechanism of rescue by P2X4 receptors in cardiomyopathy.

  2009cited by this paper
• G-CSF exerts dual effects on endothelial cells--opposing actions of direct eNOS induction versus indirect CRP elevation.

  2008cited by this paper
• Granulocyte colony-stimulating factor therapy for cardiac repair after acute myocardial infarction: a systematic review and meta-analysis of randomized controlled trials.

  2008cited by this paper
• Novel polymer carriers and gene constructs for treatment of myocardial ischemia and infarction.

  2008cited by this paper
• Prevention of Ventricular Arrhythmias With Sarcoplasmic Reticulum Ca2+ ATPase Pump Overexpression in a Porcine Model of Ischemia Reperfusion

  2008cited by this paper
• Stem cell mobilization by granulocyte colony-stimulating factor for myocardial recovery after acute myocardial infarction: a meta-analysis.

  2008cited by this paper
• Calcium cycling and signaling in cardiac myocytes.

  2008cited by this paper
• Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy

  2008cited by this paper
• Granulocyte colony-stimulating factor exacerbates cardiac fibrosis after myocardial infarction in a rat model of permanent occlusion.

  2008cited by this paper
• Recombinant adeno-associated virus transduction and integration.

  2008cited by this paper
• Reversal of cardiac dysfunction after long-term expression of SERCA2a by gene transfer in a pre-clinical model of heart failure.

  2008cited by this paper
• Percutaneous cardiac recirculation-mediated gene transfer of an inhibitory phospholamban peptide reverses advanced heart failure in large animals.

  2007cited by this paper
• Restoration of mechanical and energetic function in failing aortic-banded rat hearts by gene transfer of calcium cycling proteins.

  2007cited by this paper
• S100A1: a novel inotropic regulator of cardiac performance. Transition from molecular physiology to pathophysiological relevance.

  2007cited by this paper
• Effectiveness and tolerability of administration of granulocyte colony-stimulating factor on left ventricular function in patients with myocardial infarction: a meta-analysis of randomized controlled trials.

  2007cited by this paper
• Administration of Granulocyte Colony‐Stimulating Factor After Myocardial Infarction Enhances the Recruitment of Hematopoietic Stem Cell‐Derived Myofibroblasts and Contributes to Cardiac Repair

  2007cited by this paper
• Darbepoetin Alfa Protects the Rat Heart Against Infarction: Dose-Response, Phase of Action, and Mechanisms

  2007cited by this paper
• G-CSF therapy for acute myocardial infarction.

  2007cited by this paper
• Feasibility and safety of granulocyte colony-stimulating factor treatment in patients with acute myocardial infarction.

  2007cited by this paper
• Adrenal adrenoceptors in heart failure: fine-tuning cardiac stimulation.

  2007cited by this paper
• Stable Myocardial-Specific AAV6-S100A1 Gene Therapy Results in Chronic Functional Heart Failure Rescue

  2007cited by this paper
• Adenylylcyclase Gene Transfer Increases Function of the Failing Heart

  2006cited by this paper
• Increased Cardiac Adenylyl Cyclase Expression Is Associated With Increased Survival After Myocardial Infarction

  2006cited by this paper
• Safety of granulocyte-colony-stimulating factor in acute myocardial infarction (the Rigenera study)

  2006cited by this paper
• Inhibition of protein phosphatase 1 by inhibitor‐2 gene delivery ameliorates heart failure progression in genetic cardiomyopathy

  2006cited by this paper
• Granulocyte Colony Stimulating Factor Directly Inhibits Myocardial Ischemia-Reperfusion Injury Through Akt–Endothelial NO Synthase Pathway

  2006cited by this paper
• G‐CSF administration after myocardial infarction in mice attenuates late ischemic cardiomyopathy by enhanced arteriogenesis

  2006cited by this paper
• Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial.

  2006cited by this paper
• Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSF-STEMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infarc

  2006cited by this paper
• Autologous Bone Marrow Stem Cell Mobilization Induced by Granulocyte Colony-Stimulating Factor After Subacute ST-Segment Elevation Myocardial Infarction Undergoing Late Revascularization : Final Results From the G-CSF-STEMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infar

  2006cited by this paper
• Cardiac S100A1 Protein Levels Determine Contractile Performance and Propensity Toward Heart Failure After Myocardial Infarction

  2006cited by this paper
• Cardioprotective effects of granulocyte colony-stimulating factor in swine with chronic myocardial ischemia.

  2006cited by this paper
• Granulocyte colony-stimulating factor attenuates early ventricular expansion after experimental myocardial infarction

  2006cited by this paper
• Treatment with granulocyte colony-stimulating factor ameliorates chronic heart failure

  2006cited by this paper
• A Single Bolus of a Long-acting Erythropoietin Analogue Darbepoetin Alfa in Patients with Acute Myocardial Infarction: A Randomized Feasibility and Safety Study

  2006cited by this paper
• Stem Cell Mobilization Induced by Subcutaneous Granulocyte-Colony Stimulating Factor to Improve Cardiac Regeneration After Acute ST-Elevation Myocardial Infarction: Result of the Double-Blind, Randomized, Placebo-Controlled Stem Cells in Myocardial Infarction (STEMMI) Trial

  2006cited by this paper
• Granulocyte colony-stimulating factor attenuates early ventricular expansion after experimental myocardial infarction.

  2005cited by this paper
• Enhancement of Cardiac Function and Suppression of Heart Failure Progression By Inhibition of Protein Phosphatase 1

  2005cited by this paper
• Hematopoietic stem cells do not repair the infarcted mouse heart.

  2005cited by this paper
• Enhanced cardiac function in mice overexpressing protein phosphatase Inhibitor-2.

  2005cited by this paper
• Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profile.

  2005cited by this paper
• Prevention of Left Ventricular Remodeling With Granulocyte Colony-Stimulating Factor After Acute Myocardial Infarction: Final 1-year Results of the Front-Integrated Revascularization and Stem Cell Liberation in Evolving Acute Myocardial Infarction by Granulocyte Colony-Stimulating Factor (FIRSTLINE-

  2005cited by this paper
• Preservation From Left Ventricular Remodeling by Front-Integrated Revascularization and Stem Cell Liberation in Evolving Acute Myocardial Infarction by Use of Granulocyte-Colony–Stimulating Factor (FIRSTLINE-AMI)

  2005cited by this paper
• Reduced inhibitor 1 and 2 activity is associated with increased protein phosphatase type 1 activity in left ventricular myocardium of one-kidney, one-clip hypertensive rats

  2005cited by this paper
• G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes

  2005cited by this paper
• Expression of the erythropoietin receptor in human heart.

  2005cited by this paper
• Mechanisms of erythropoietin‐mediated cardioprotection during ischemia‐reperfusion injury: role of protein kinase C and phosphatidylinositol 3‐kinase signaling

  2005cited by this paper
• Cytokine therapy prevents left ventricular remodeling and dysfunction after myocardial infarction through neovascularization

  2004cited by this paper
• Indirect intracoronary delivery of adenovirus encoding adenylyl cyclase increases left ventricular contractile function in mice.

  2004cited by this paper
• Acute cardioprotective effects of erythropoietin in infant rabbits are mediated by activation of protein kinases and potassium channels

  2004cited by this paper
• Phospholamban gene ablation improves calcium transients but not cardiac function in a heart failure model.

  2004cited by this paper
• The myocardial protein S100A1 plays a role in the maintenance of normal gene expression in the adult heart

  2004cited by this paper
• Targeted beta-adrenergic receptor kinase (betaARK1) inhibition by gene transfer in failing human hearts.

  2004cited by this paper
• Comparative analysis of parvalbumin and SERCA2a cardiac myocyte gene transfer in a large animal model of diastolic dysfunction.

  2004cited by this paper
• Manipulating Cardiac Contractility in Heart Failure: Data From Mice and Men

  2004cited by this paper
• Effects of G-CSF on cardiac remodeling after acute myocardial infarction in swine.

  2004cited by this paper
• Acceleration of the Healing Process and Myocardial Regeneration May Be Important as a Mechanism of Improvement of Cardiac Function and Remodeling by Postinfarction Granulocyte Colony–Stimulating Factor Treatment

  2004cited by this paper
• Decreased protein and phosphorylation level of the protein phosphatase inhibitor-1 in failing human hearts.

  2004cited by this paper
• Cardiac adenoviral S100A1 gene delivery rescues failing myocardium.

  2004cited by this paper
• Intracoronary Adenovirus Encoding Adenylyl Cyclase VI Increases Left Ventricular Function in Heart Failure

  2004cited by this paper
• Targeted &bgr;-Adrenergic Receptor Kinase (&bgr;ARK1) Inhibition by Gene Transfer in Failing Human Hearts

  2004cited by this paper
• Constitutive Cardiac Overexpression of Sarcoplasmic/Endoplasmic Reticulum Ca2+-ATPase Delays Myocardial Failure After Myocardial Infarction in Rats at a Cost of Increased Acute Arrhythmias

  2004cited by this paper
• Abrogation of ventricular arrhythmias in a model of ischemia and reperfusion by targeting myocardial calcium cycling.

  2004cited by this paper

• The role of circulating cytokines in heart failure: a bidirectional, two-sample Mendelian randomization study

  2024cites this paper
• Molecular Mechanism of Wenyang Zhenshuai Granule in Treatment of Chronic Heart Failure via Network pharmacology

  2024cites this paper
• Myocardial protection by heparin-based coacervate of FGF10

  2020cites this paper
• Application of G-CSF in Congestive Heart Failure Treatment

  2019cites this paper
• Cytokines as therapeutic agents and targets in heart disease.

  2018cites this paper
• Fibroblast Growth Factor-1 Released from a Heparin Coacervate Improves Cardiac Function in a Mouse Myocardial Infarction Model.

  2017cites this paper
• A Minimally Invasive, Translational Method to Deliver Hydrogels to the Heart Through the Pericardial Space

  2017cites this paper
• MicroRNAs in oral lichen planus and potential miRNA-mRNA pathogenesis with essential cytokines: a review.

  2016cites this paper
• The effects of transplanted cells in stem cell therapy for myocardial ischemia

  2016cites this paper
• Benecios del entrenamiento físico en sujetos con cardiopatía isquémica Fitness benets in patients with ischemic heart disease

  2016cites this paper
• СОВРЕМЕННЫЕ ПРЕДСТАВЛЕНИЯ О КЛЕТОЧНО-МОЛЕКУЛЯРНЫХ МЕХАНИЗМАХ АНГИОГЕНЕЗА

  2015cites this paper
• Advances in gene therapy for heart failure.

  2015cites this paper
• Stimulating endogenous cardiac repair

  2015cites this paper
• Controlled dual delivery of fibroblast growth factor-2 and Interleukin-10 by heparin-based coacervate synergistically enhances ischemic heart repair.

  2015cites this paper
• Umbilical Cord Blood for Cardiovascular Cell Therapy

  2014cites this paper
• The use of MMP2 antibody-conjugated cationic microbubble to target the ischemic myocardium, enhance Timp3 gene transfection and improve cardiac function.

  2014cites this paper
• IL-33 attenuates cardiac remodeling following myocardial infarction via inhibition of the p38 MAPK and NF-κB pathways.

  2014cites this paper
• Fitness benefits in patients with ischemic heart disease.

  2013cites this paper
• miR-128 regulates non-myocyte hyperplasia, deposition of extracellular matrix and Islet1 expression during newt cardiac regeneration.

  2013influential citation
• The Challenges for Cardiac Vascular Precursor Cell Therapy: Lessons from a Very Elusive Precursor

  2013cites this paper
• Tissue Development, Repair, and Remodeling

  2013cites this paper
• Update on innovative initiatives for the American Journal of Physiology-Heart and Circulatory Physiology.

  2013cites this paper
• Noninvasive imaging of myocardial extracellular matrix for assessment of fibrosis

  2013cites this paper
• Cardiac regenerative medicine 2.0

  2008cites this paper